Evidence map›Paper›PMID 41472739›Full record

ArticleFrontiers in immunology2025

Ameliorative effects and mechanism of

Yan Song, Rui Lin, Yifeng Fu, Anna Wang, Hu Yang, Wentian Liu

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yan SongDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Rui LinDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.
Yifeng FuCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, Hunan, China.
Anna WangCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, Hunan, China.
Hu YangDepartment of Nephrology, Tianjin Medical University No.2 Hospital, Tianjin, China.
Wentian LiuDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: As a complex and persistent inflammatory bowel disease, the onset and progression of ulcerative colitis (UC) are closely associated with intestinal microbiota dysbiosis, host metabolic imbalance, and impaired intestinal barrier function. The traditional Chinese medicine Methods: A colitis model was established by inducing UC in ICR mice using dextran sulfate sodium (DSS). The experimental animals were divided into four groups: normal control group (CON), normal administration group (CONSQ), DSS-induced model group (DSS), and DSS-induced administration group (DSSSQ). The CONSQ and DSSSQ groups received oral gavage of 200 mg/kg Results: Treatment with Discussion: The results of this study demonstrate that

Indexed as

Anti-Inflammatory AgentsColitis, UlcerativeGastrointestinal MicrobiomePanax notoginsengPlant ExtractsAnimalsColonDextran SulfateDisease Models, AnimalDrugs, Chinese HerbalIntestinal MucosaMaleMetabolomicsMiceMice, Inbred ICRMultiomicsAnti-Inflammatory AgentsDextran SulfateDrugs, Chinese HerbalPanax notoginseng extractPlant Extractsgut microbeshealth effectsintestinal barriernatural compoundsP. notoginseng extractulcerative colitis

Identifiers

PMID41472739
PMCPMC12745257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.